What is Merck & Co.'s common stock, par value (in dollars per share)?

Merck & Co. (MRK) reported common stock, par value (in dollars per share) of $0.50 in Q1 2026.

How has Merck & Co.'s common stock, par value (in dollars per share) changed year-over-year?

Merck & Co.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0.50 to $0.50.

What is the long-term trend for Merck & Co.'s common stock, par value (in dollars per share)?

Over 5 years (2020 to 2025), Merck & Co.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0.50 to $0.50.

Merck & Co. MRK Common stock, par value (in dollars per share)

Common stock, par value (in dollars per share) at other companies

ImmunityBio, Inc.IBRX

——

ZoetisZTS

——

Summit TherapeuticsSMMT

——

Spyre Therapeutics, Inc.SYRE

——

Vaxcyte, Inc.PCVX

——

Arcus BiosciencesRCUS

——

Other financials

Income statement

See full

Revenue$16.3B+4.9%

Gross profit$12.1B-0.2%

Net income-$4.2B-183%

EPS (diluted)-$1.72-186%

Balance sheet

See full

Cash & equivalents$5.4B-38.2%

Total debt$49.1B+35.8%

Total equity$45.9B-5.1%

Total assets$128.69B+11.8%

Cash flow

See full

Operating cash flow$3.9B+56.7%

CapEx$991.0M-25.4%

Free cash flow$2.9B+150%

Valuation

See full

Market cap$317.37B+61.7%

Enterprise value$361.07B+60.4%

P/E35.5×+23.6×

P/S4.8×+1.7×

Profitability

See full

Gross margin73.9%-2.5pp

Net margin13.6%-13.7pp

FCF margin21.5%-5.2pp

Returns & leverage

See full

Return on equity19%-20.3pp

Debt / equity1.1×+0.3×

Current ratio1.3×-0.1×

Where this comes from

Reported directly by Merck & Co. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The official record: Merck & Co.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merck & Co.'s common stock, par value (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Merck & Co.'s common stock, par value (in dollars per share)?: Merck & Co. (MRK) reported common stock, par value (in dollars per share) of $0.50 in Q1 2026.
How has Merck & Co.'s common stock, par value (in dollars per share) changed year-over-year?: Merck & Co.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0.50 to $0.50.
What is the long-term trend for Merck & Co.'s common stock, par value (in dollars per share)?: Over 5 years (2020 to 2025), Merck & Co.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0.50 to $0.50.